These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2656706

  • 1. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
    Yu G, Smithgall TE, Glazer RI.
    J Biol Chem; 1989 Jun 15; 264(17):10276-81. PubMed ID: 2656706
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias.
    Carlson A, Berkowitz JM, Browning D, Slamon DJ, Gasson JC, Yates KE.
    DNA Cell Biol; 2005 May 15; 24(5):311-6. PubMed ID: 15869408
    [Abstract] [Full Text] [Related]

  • 6. p210Bcr/Abl and p160v-Abl induce an increase in the tyrosine phosphorylation of p93c-Fes.
    Ernst TJ, Slattery KE, Griffin JD.
    J Biol Chem; 1994 Feb 25; 269(8):5764-9. PubMed ID: 8119916
    [Abstract] [Full Text] [Related]

  • 7. Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
    Yu G, Grant S, Glazer RI.
    Mol Pharmacol; 1988 Apr 25; 33(4):384-8. PubMed ID: 3162757
    [Abstract] [Full Text] [Related]

  • 8. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
    Ferrari S, Manfredini R, Tagliafico E, Grande A, Barbieri D, Balestri R, Pizzanelli M, Zucchini P, Citro G, Zupi G.
    Leukemia; 1994 Apr 25; 8 Suppl 1():S91-4. PubMed ID: 8152313
    [Abstract] [Full Text] [Related]

  • 9. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
    Lionberger JM, Smithgall TE.
    Cancer Res; 2000 Feb 15; 60(4):1097-103. PubMed ID: 10706130
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional regulation of c-Fes in myeloid leukemia cells.
    He Y, Borellini F, Koch WH, Huang KX, Glazer RI.
    Biochim Biophys Acta; 1996 May 02; 1306(2-3):179-86. PubMed ID: 8634335
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ, Peters KL, Briggs SD, Glazer RI, Smithgall TE.
    Oncogene; 1993 Aug 02; 8(8):2283-92. PubMed ID: 7687763
    [Abstract] [Full Text] [Related]

  • 12. Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene.
    Borellini F, He YF, Aquino A, Yu G, Josephs SF, Glazer RI.
    J Biol Chem; 1991 Aug 25; 266(24):15850-4. PubMed ID: 1874737
    [Abstract] [Full Text] [Related]

  • 13. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.
    Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC.
    Mol Cell Biol; 1996 Apr 25; 16(4):1676-86. PubMed ID: 8657143
    [Abstract] [Full Text] [Related]

  • 14. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA, Cheng HY, Smithgall TE.
    Cell Growth Differ; 2000 Nov 25; 11(11):581-92. PubMed ID: 11095247
    [Abstract] [Full Text] [Related]

  • 15. The c-Fes family of protein-tyrosine kinases.
    Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N.
    Crit Rev Oncog; 1998 Nov 25; 9(1):43-62. PubMed ID: 9754447
    [Abstract] [Full Text] [Related]

  • 16. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.
    Brach MA, Gauer E, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F.
    Int J Cell Cloning; 1991 Jan 25; 9(1):89-94. PubMed ID: 2010659
    [Abstract] [Full Text] [Related]

  • 17. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells.
    Manfredini R, Balestri R, Tagliafico E, Trevisan F, Pizzanelli M, Grande A, Barbieri D, Zucchini P, Citro G, Franceschi C, Ferrari S.
    Blood; 1997 Jan 01; 89(1):135-45. PubMed ID: 8978286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.
    Kim J, Feldman RA.
    Mol Cell Biol; 2002 Mar 01; 22(6):1903-18. PubMed ID: 11865067
    [Abstract] [Full Text] [Related]

  • 20. Human c-FES is a nuclear tyrosine kinase.
    Yates KE, Lynch MR, Wong SG, Slamon DJ, Gasson JC.
    Oncogene; 1995 Mar 16; 10(6):1239-42. PubMed ID: 7700650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.